Fmoc-(Dmb)Gly-OH is an Fmoc-protected glycine derivative bearing a (Dmb) substituent on the amino acid side chain, where (Dmb) denotes a 2,4-dimethoxybenzyl-type protecting group on the relevant functional position. The molecule contains an Fmoc carbamate protecting the amino group and a free carboxylic acid functionality, with the aromatic (Dmb) group providing steric and electronic modulation of the substituted position while the stereochemical form is specified as D for the (Dmb)Gly framework. In peptide chemistry, this protected amino acid is employed as a building block for stepwise assembly in solid-phase or solution-phase synthesis, where the protecting groups support chemoselective coupling and the carboxyl group participates in formation of peptide bonds.
CAT No: CP26474
CAS No:166881-42-1
Synonyms/Alias:Fmoc-(Dmb)Gly-OH;166881-42-1;Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH;Fmoc-Gly(Dmb)-OH;Fmoc-N-(2,4-dimethoxybenzyl)glycine;2-[(2,4-dimethoxyphenyl)methyl-(9H-fluoren-9-ylmethoxycarbonyl)amino]acetic Acid;Glycine, N-[(2,4-dimethoxyphenyl)methyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;MFCD08064316;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(2,4-dimethoxybenzyl)glycine;DTXSID90444217;Fmoc-Dmb-Gly-OH;{[(2,4-DIMETHOXYPHENYL)METHYL][(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}ACETIC ACID;Fmoc-N-(2,4-dimethoxybenzyl)-glycine;DTXCID90395038;UIDQSTVPYKMCEY-UHFFFAOYSA-N;EX-A3848;AKOS015911836;FD21648;GS-6398;HY-W047794;DA-73419;PD197177;SY073468;CS-0099800;Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH, >=98.0% (HPLC);2-{[(2,4-dimethoxyphenyl)methyl]({[(9H-fluoren-9-yl)methoxy]carbonyl})amino}acetic acid;623-771-0;
Fmoc-(Dmb)Gly-OH is a fluorenylmethoxycarbonyl (Fmoc) protected glycine derivative bearing a side-chain functional group at the amino acid level through the (Dmb) motif, corresponding to a Dmb-substituted glycine framework with defined stereochemical identity at the substituted center. The molecule contains an Fmoc carbamate on the amino function, a free carboxylic acid for C-terminal activation, and a benzylic/aryl-associated Dmb substituent that can participate in selective transformations depending on the protecting-group stability under peptide synthesis conditions. The aromatic Fmoc chromophore supports monitoring and purification in peptide workflows, while the carboxylic acid enables standard amide bond formation after activation. The overall reactivity profile is tuned for orthogonal protection strategies, allowing controlled deprotection and downstream conversion of the Dmb-bearing side-chain into functional handles for peptide and peptidomimetic construction.
1. Peptide Synthesis
Fmoc-(Dmb)Gly-OH is applied in solid-phase peptide synthesis where the Fmoc-protected amine supports iterative N-terminal deprotection and coupling cycles. The free carboxylic acid provides the C-terminal functionality needed for peptide coupling chemistry, while the aromatic Fmoc group enables UV-active tracking of resin-bound intermediates. The (Dmb) substitution pattern can be selected to remain stable during standard coupling and base-mediated Fmoc removal, supporting the incorporation of a functionalized glycine residue into peptide backbones. Downstream, the Dmb-bearing side-chain can be leveraged for post-assembly modifications or for building peptide analog libraries that require defined side-chain functionality.
2. Side-Chain Functionalization
Fmoc-(Dmb)Gly-OH is used for amino acid derivatization and side-chain functionalization strategies in synthetic organic chemistry and chemical biology. The Dmb-substituted glycine framework introduces a substituent that can serve as a masked or transformable group, enabling conversion into alternative functional moieties after peptide assembly or during intermediate synthesis planning. The orthogonal presence of the Fmoc carbamate and the free acid allows sequential manipulation, including controlled deprotection and activation steps that preserve stereochemical integrity of the chiral amino acid intermediate. Resulting derivatives can be used to generate functionalized peptide fragments, peptidomimetics, or reagent-grade amino acid building blocks for further conjugation chemistry.
3. Chiral Building Block Synthesis
Fmoc-(Dmb)Gly-OH serves as a chiral amino acid intermediate for stereodefined synthesis of functional peptide building blocks and chiral molecular scaffolds. The stereochemical specification associated with the Dmb-substituted glycine architecture supports incorporation into sequences where stereochemistry influences conformational bias and molecular recognition. The Fmoc-protected amine and carboxylic acid pairing enables compatibility with protected-amino-acid synthesis workflows, including activation to form amide bonds while maintaining the protected functional groups through multi-step routes. Downstream utility includes preparing stereochemically defined fragments for structure-activity relationship studies and for generating libraries of chiral peptidomimetic candidates.
4. Bioconjugation Chemistry
Fmoc-(Dmb)Gly-OH is suitable for bioconjugation chemistry workflows that require peptide-derived linkers or functional handles introduced at a glycine position. The presence of a protected amine and a carboxylic acid facilitates incorporation into peptide segments that can later be converted into conjugation-ready constructs, such as peptide tags, affinity reagents, or multivalent scaffolds. The Dmb-bearing side-chain can be used as a controllable functional element for post-synthetic transformation, supporting orthogonal labeling strategies that minimize interference with other reactive groups on biomolecules. Resulting conjugates can be applied in chemical biology experiments and analytical assays where defined attachment chemistry and residue-level control are required.
5. Pharmaceutical Intermediate Preparation
Fmoc-(Dmb)Gly-OH is relevant to pharmaceutical intermediate preparation and process chemistry for producing protected amino acid derivatives used in peptide-like active ingredient synthesis. The Fmoc carbamate and free carboxylic acid establish a manufacturing-compatible protected amino acid format that can be incorporated into longer sequences or converted into activated intermediates under controlled conditions. The aromatic Fmoc group supports process monitoring and purification during protected-amino-acid handling, while the Dmb functionality provides a handle for downstream derivatization aligned with synthetic route design. The compound can therefore function as a residue-level intermediate for fine chemical production of peptide intermediates and for generating stereochemically defined building blocks used in industrial peptide synthesis campaigns.
6. Analytical Research Standards
Fmoc-(Dmb)Gly-OH is utilized in analytical research as a reference material and characterization standard for protected amino acid and peptide fragment analysis. The Fmoc chromophore provides strong UV/fluorescence response, supporting detection in HPLC/UPLC workflows and enabling monitoring of deprotection and coupling-related transformations. The defined Dmb-substituted glycine structure supports method development for identifying residue-specific fragments, verifying incorporation of functionalized glycine units, and validating identity of peptide building blocks. Downstream, the compound supports quality control of peptide synthesis intermediates and supports analytical method transfer in research and industrial settings focused on amino acid derivative characterization.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.